Quality is integrated into all of our clinical and pharmaceuticals practices at Zi Diligence research center. We are nationally and internationally accredited in the field of pharmaceutical and clinical research in MENA region. Aiming to be the most reliable and service oriented research center in pharmaceutical and clinical fields. Our experience and oversight ensure that our clinical, bio-analytical and related services comply with Gulf Cooperation Council (GCC) Standardized to “Good Clinical Practice (GCP)” and “Good Laboratory Practice (GLP), Food and Drug Administration (FDA), International Conference on Harmonization (ICH) GCP guidelines. 

At Zi Diligence, we build quality into all our services.

A key way to achieve this is by operating a Quality Management System (QMS) in accordance with the requirements of ISO 17025:2017 and ISO 9001: 2015.

To this end, Zi Diligence Research Center top management is proudly committed to provide our services through the following:

1. Establish, implement and maintain the quality policy that is appropriate to the purpose and context of the organization, supports its strategic direction and testing activities.
2. Satisfying applicable requirements by ensuring that interested parties and applicable statutory and regulatory requirements are determined, understood and consistently met.
3. Continual improvement of the QMS by ensuring the risks and opportunities that can affect conformity of products and services and the ability to enhance customer satisfaction are determined and addressed and the focus on enhancing customer satisfaction is maintained.
4. Ensure the quality policy and quality objectives are established for the QMS and are compatible with the context and strategic direction of the Company. Quality objectives have been set and are maintained as part of the QMS internal auditing, monitoring and management review processes, in order to enhance customer satisfaction.

• Establish partnerships with suppliers and interested parties to provide an improved service.
• Engage, direct and support personnel to contribute to the effectiveness of the QMS; polices and procedures by ensuring proper communication, promote improvement and to support other relevant management roles to demonstrate their leadership as it applies to their areas of responsibility.
• Continual improvement by using the most advanced techniques and equipments in addition to passionate and dedicated team of Zi Diligence.
• Design and operate the facilities and processes in compliance with the national and international Guidelines and standards ; ICH-GCP, EMA, GCC, EDA, GLP, FDA, WHO, ISO 9001:2015 and ISO/IEC 17025 : 2017 and local guidelines.
• Maintain expertise in GCP, GLP and ICH to enhance employees comptencies and other job skills impacting quality through ongoing training programs, including the training of employees to meet the specific requirements of each study.

10. Zi Diligence staff understands and is fully aware of the importance of management of impartiality and confidentiality in carrying out their testing activities.
11. Zi-diligence has documented structures, policies and procedures to manage impartiality and confidentiality to ensures that the testing activities are undertaken impartially,
12. Top management is commited to impartiality and confidentiality in testing activities.
13. Zi Diligence analyzes, documents and eliminates the potential conflict of interests arising from its testing activities which are structured and managed so as to safeguard impartiality and confidentiality.